Impaired Glucose Tolerance Completed Phase 3 Trials for Ramipril (DB00178)

Also known as: Prediabetic State (IGT) / Impaired Glucose Tolerance (IGT) / IGT - Impaired Glucose Tolerance / Glucose tolerance impaired / Impaired Glucose Tolerance (Prediabetes) / Pre-diabetic State / Prediabetic State / Pre-Diabetic / Pre Diabetes / Pre-Diabetes / Pre Diabetic / Prediabetes / Prediabetic / Latent diabetes / Chemical diabetes / Glucose intolerance / Malabsorption of glucose (disorder) / Impaired glucose tolerance (disorder) / Prediabetes (finding) / Borderline diabetes

IndicationStatusPhase
DBCOND0030184 (Impaired Glucose Tolerance)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00489229To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT PatientsTreatment
NCT00140647The Study of Atherosclerosis With Ramipril and RosiglitazonePrevention
NCT00095654The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) TrialPrevention